RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|9|1|45-50

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.1, 2016-01, pp. : 45-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 478-483

Karger

Access to resources Recommend Favorite

Overcoming Resistance to EGFR Inhibitors in NSCLC

By  

Reviews on Recent Clinical Trials, Vol. 11, Iss. 2, 2016-06 ,pp. : 99-105

Bentham Science Publishers

Access to resources Recommend Favorite

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2947-2958

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 83-94

Karger

Access to resources Recommend Favorite

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 228-233

Bentham Science Publishers

Access to resources Recommend Favorite